Predictive factors for long-term effects of imatinib therapy in patients with inoperable/metastatic CD117(+) gastrointestinal stromal tumors (GISTs)

By Rutkowski Piotr   Nowecki Zbigniew   Dębiec-Rychter Maria   Grzesiakowska Urszula   Michej Wanda   Woźniak Agnieszka   Siedlecki Janusz   Limon Janusz   Dobosz Anna   Kąkol Michał   Osuch Czesław   Ruka Włodzimierz  

Journal of Cancer Research and Clinical Oncology, Vol. 133, Iss. 9, 2007-09 ,pp. : 589-597

Springer Publishing Company

Access to resources Recommend Favorite

Imatinib mesylate-induced acute liver failure in a patient with gastrointestinal stromal tumors

By Tonyali Onder   Coskun Ugur   Yildiz Ramazan   Karakan Tarkan   Demirci Umut   Akyurek Nalan   Benekli Mustafa   Buyukberber Suleyman  

Medical Oncology, Vol. 27, Iss. 3, 2010-09 ,pp. : 768-773

Humana Press, Inc

Access to resources Recommend Favorite

Surgical Resection of Gastrointestinal Stromal Tumors After Treatment with Imatinib

By Andtbacka Robert   Ng Chaan   Scaife Courtney   Cormier Janice   Hunt Kelly   Pisters Peter   Pollock Raphael   Benjamin Robert   Burgess Michael   Chen Lei   Trent Jonathan   Patel Shreyaskumar   Raymond Kevin   Feig Barry  

Annals of Surgical Oncology, Vol. 14, Iss. 1, 2007-01 ,pp. : 14-24

Springer Publishing Company

Access to resources Recommend Favorite

Serum Midkine Correlates with Tumor Progression and Imatinib Response in Gastrointestinal Stromal Tumors

By Rawnaq Tamina  

Annals of Surgical Oncology, Vol. 18, Iss. 2, 2011-02 ,pp. : 559-565

Springer Publishing Company

Access to resources Recommend Favorite

Simultaneously occurring chronic myelogenous leukemia and gastrointestinal stromal tumors treated with imatinib

By Mishima Y.  

Targeted Oncology, Vol. 1, Iss. 3, 2006-07 ,pp. : 168-171

Springer Publishing Company

Access to resources Recommend Favorite